← SynDRA
CHLOROTRIANISENE
SynDRA canonical compound SYN0023176 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | ESR1 |
|---|
| Mechanism of action | Estrogen receptor agonist |
|---|
| Indication | menopause | prostate cancer |
|---|
| Disease area | endocrinology | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- ESR1 AGONIST
- ESR2 MODULATOR
- ESR1 BINDER
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR1I2
- ADORA1
- MAPT
- NR3C1
- NPY1R
- NPSR1
- NFE2L2
- MLNR
- MC4R
- MC3R
- MAPK1
- ADORA2A
- MAOA
- LMNA
- KDM4E
- KCNH2
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- TSHR
- TDP1
- TBXA2R
- SMN1
- SLCO1B3
- SLCO1B1
- SLC6A4
- SLC6A3
- SLC6A2
- SLC29A1
- SAMHD1
- RORC
- RAPGEF4
- PTGS2
- PPARG
- PGR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ANDR
- CP19A
- CP2C9
- CP2CJ
- ESRRA
- GCR
- NR1H4
- PRGR
- RPGF4
Drug classes
- Antineoplastic Agents
- Antineoplastic Agents, Hormonal
- Estrogens
- Estrogens, Non-Steroidal
- Hormones
- estrogenic hormone
ATC classes
Cross-references
Synonyms
- TACE
- chlortrianizen
- clorotrisin
- hormonisene
- khlortrianizen
- clorotrianisene
- Clorotrianiseno
- Adam17
- Snake venom-like protease
- Tnf-alpha convertase
- Tnf-alpha-converting enzyme
- NSC-10108
- Tace
- Anisene
- Chloortrianisestrol
- Chlorestrolo
- Chlorotrianisenum
- Chlorotrianisestrol
- Chlorotrianisine
- Chlorotrianizen
- Chlorotrisin
- Chlortrianisen
- Chlortrianisene
- Chlortrianisenum
- Chlortrianisestrol
- Chlortrianisoestrolum
- Chlortrianizen
- Clorestrolo
- Clorotrianisene
- Clorotrisin
- Hormonisene
- Khlortrianizen
- Merbentul
- Metace
- Rianil
- Triagen
- Trianisestrol
Look up CHLOROTRIANISENE in the interactive SynDRA portal →